Kagoshima, Japan

Shin-ichi Akiyama


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1992-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Shin-ichi Akiyama

Introduction

Shin-ichi Akiyama is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the effects of antitumor drugs. With a total of 3 patents to his name, Akiyama's work is recognized for its potential impact on cancer treatment.

Latest Patents

Akiyama's latest patents include a phosphorus pyridine compound that serves as an agent for enhancing the drug effects of antitumor medications. This compound comprises a specific formula that allows for improved efficacy in drug treatments. Another significant patent is a drug effect-enhancing agent for antitumor drugs, which includes compounds that feature a nitrogen-containing hetero ring portion. These innovations are designed to enhance the antitumor effects of existing drugs, showcasing Akiyama's commitment to advancing medical science.

Career Highlights

Shin-ichi Akiyama is currently associated with Nissan Chemical Industries Limited, where he continues to develop innovative solutions in the pharmaceutical sector. His work is characterized by a focus on creating compounds that can significantly improve the effectiveness of cancer therapies.

Collaborations

Akiyama has collaborated with notable colleagues such as Ryozo Sakoda and Kiyotomo Seto. Their combined expertise has contributed to the successful development of Akiyama's patents and innovations.

Conclusion

Shin-ichi Akiyama's contributions to the field of pharmaceuticals, particularly in enhancing antitumor drug efficacy, highlight his role as a significant inventor. His ongoing work promises to make a meaningful impact on cancer treatment in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…